After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

The global urinary antibacterial and antiseptic pharmaceuticals market is projected to grow at a robust Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period, driven by increasing ...

GSK Plc said its blood cancer drug significantly reduced the risk of death when combined with another cancer treatment, ...

New Zealand's healthcare system is outperforming Sweden's, Canada's and Germany's, according to a top-level financial presentation to Te Whatu Ora staff. The financial performance briefing by the ...

Kiwi startup OpenStar's bold move to use levitating dipole reactor for fusion achieved a key milestone with its first plasma.

The 3,000-metre distillery has been unveils in the same year the New Zealand spirits brand celebrates a decade in business ...

Ormat Technologies has secured a contract for the development of the 101MW Te Mihi Stage 2 geothermal power plant in New ...

New Zealand’s banking landscape faces significant changes as new players target different segments, potentially disrupting ...

New Zealand food manufacturers are beginning to embrace the circular economy but are up against a lack of government support, ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

Though GSK has put considerable effort into developing pharmacological treatments for gynecological cancers—including Zejula, ...

Pacific Trade Invest NZ invites you to an important webinar on the FMCG industry in New Zealand. This will be of great ...